The Renal Association has produced guidance on best practice in the management of patients with kidney disease since 1995. The current editions of the Guidelines can be found in the table below, along with commentaries on other relevant guidelines.
|Guideline||Authors||Publication Date||Review Date|
|Treatment of acute hyperkalaemia in adults|
Hyperkalaemia algorithm - community
Hyperkalaemia algorithm - hospital
Hyperkalaemia algorithm - cardiac arrest
|Dr Annette Alfonzo, Dr Alexander Harrison, Dr Richard Baines, Dr Ann Chu, Mr Simon Mann, Mr Murdoch MacRury||July 2020||2025|
|Standardisation of immunosuppressive and anti-infective drug regimens in UK Paediatric Renal transplantation: The Harmonisation programme||Jan Dudley, Stephen Marks, Martin Christian, Alice Andrews, Nicola Andrews, Julie Baker, Sheila Boyle, Mairead Convery, Fiona Gamston, Martin Garcia, Shuman Haq, Shivram Hegde, Richard Holt, Helen Jones, Shakeeb Khan, Jennifer McCaughan, David Milford, Charlie Pickles, Ben Reynolds, Vijaya Sathyanarayana, Jelena Stojanovic, Yincent Tse, Dean Wallace, Grainne Walsh, Nick Ware, Alun Williams, Pallavi Yadav||May 2020||2025|
|Commentary on the NICE Guideline on RRT and conservative management||Kunaal Kharbanda, Osasuyi Iyasere, Fergus Caskey, Matko Marlais, Sandip Mitra||March 2020||2025|
|Commentary on the NICE COVID-19 rapid guideline: dialysis service delivery||Michael Robson, James Burton, Sharlene Greenwood, Karen Jenkins, Maarten Taal||March 2020||TBC|
|Pregnancy and Renal Disease||Kate Wiles, Lucy Chappell, Katherine Clark, Louise Elman, Matt Hall, Liz Lightstone, Germin Mohamed, Durba Mukherjee, Catherine Nelson-Piercy, Philip Webster, Rebecca Whybrow & Kate Bramham||September 2019||2024|
|Acute Kidney Injury (AKI)||Suren Kanagasundaram, Caroline Ashley, Sheetal Bhojani, Alma Caldwell, Timothy Ellam, Amrit Kaur, David Milford, Chris Mulgrew, Marlies Ostermann||August 2019||2024|
|Haemodialysis||Damien Ashby, Natalie Borman, James Burton, Richard Corbett, Andrew Davenport, Ken Farrington, Katey Flowers, James Fotheringham, Andrea Fox, Gail Franklin, Claire Gardiner, Martin Gerrish, Sharlene Greenwood, Daljit Hothi, Abdul Khares, Pelagia Koufaki, Jeremy Levy, Elizabeth Lindley, Jamie Macdonald, Bruno Mafrici, Sandip Mitra, Andrew Mooney, James Tattersall, Kay Tyerman, Enric Villar & Marin Wilkie||July |
|Management of Blood Borne Viruses within the Haemodialysis Unit||Elizabeth Garthwaite, Veena Reddy, Sam Douthwaite, Simon Lines, Kay Tyerman & James Eccles||June 2019||2024|
|Undernutrition in Chronic Kidney Disease||Mark Wright, Elizabeth Southcott, Helen MacLaughlin, Stuart Wineberg|
Endorsed* by the Renal Nutrition Group
| Monitoring children and young people with, or at risk of developing Autosomal Dominant Polycystic Kidney Disease (ADPKD)||Jan Dudley, Paul Winyard, Matko Marlais, Oliver Cuthell, Tess Harris, Jiehan Chong, John Sayer, |
Daniel P Gale, Lucy Moore, Kay Turner, Sarah Burrows & Richard Sandford
|Commentary on the KDIGO Guideline on the Diagnosis, Evaluation, Prevention and Treatment of CKD-MBD||James Burton, David Goldsmith, Nicki Ruddock, Rukshana Shroff & Mandy Wan||June |
|Living donor kidney transplantation||Peter Andrews & Lisa Burnapp|
Endorsed by the British Transplantation Society
|Anaemia of chronic kidney disease||Ashraf Mikhail, Christopher Brown, Jennifer Ann Williams, Vinod Mathrani, Rajesh Shrivastava, Jonathan Evans, Hayleigh Isaac, Sunil Bhandari & Owain Brooks |
Updated February 2020
|Peritoneal Dialysis in Adults and Children||Graham Woodrow, Stanley Fan, Christopher Reid, Jeannette Denning & Andrew Neil Pyrah||June|
|Post-Operative Care in the Kidney Transplant Recipient||Richard Baker, Patrick Mark, Rajan Patel, Kate Stevens & Nicholas Palmer|
Endorsed by the British Transplantation Society
|Commentary on the NICE Guideline on Tolvaptan for treating autosomal dominant polycystic kidney disease||Albet CM Ong, Caroline Ashley, Tess Harris, Richard Sandford, John A Sayer, Roslyn J Simms & Grahame Wood||June|
|Water Treatment Facilities, Dialysis Water and Dialysis Fluid Quality for Haemodialysis and Related Therapies|| Nicholas Hoenich, Robert Mactier, Ian Morgan, Gerard Boyle, David Croft, Paul Rylance, Clive Thompson|
Endorsed by the Association of Renal Technologists
|Perioperative management of people with inherited salt-wasting alkaloses (Gitelman’s syndrome and Bartter’s syndrome) undergoing non-urgent surgical procedure|| Hugh Gallagher, Jasmeet Soar & Charles Tomson|
Endorsed by the Royal College of Anaesthetists
|Vascular Access for Haemodialysis||Mick Kumwenda, Sandip Mitra |
& Claire Reid
|Planning, initiation & withdrawal of Renal Replacement Therapy||Graham Warwick, Andrew Mooney, Lynne Russon & Rebecca Hardy||January|
Further guidelines and commentaries are currently being written. Please see the Recent Activity page for more information.
*caveat detailed on page 2 of the Undernutrition in Chronic Kidney Disease guideline.
The RA Clinical Practice Guidelines are not funded by any external organisation, commercial company or charity. Several of these guidelines have also been published in BMC Nephrology.
The guidelines have been accredited by the National Institute for Health and Care Excellence (NICE). The accreditation is valid until January 2022. This ensures that the Guidelines themselves will automatically be NICE accredited, providing they follow the processes laid out in the Clinical Practice Guideline Development Manual.
Accreditation helps health and social care professionals identify the most robustly produced guidance available, enabling them to deliver high quality care. More information on accreditation can be viewed at http://www.nice.org.uk/accreditation
The Renal Association’s Clinical Practice Guideline (CPG) committee have produced a Strategy Document to plan their work through until 2020.